Merlin L. Marquard

Dancing for Better Cancer Health?

Dancing is one of the – if not the – most ubiquitous cross-cultural phenomenon, but can it help you with healing cancer? And what can you learn from this about exercise and social support?

Cancer Literature Digest

Merlin L. Marquard

Mar 24, 2026 — 7 min read

On Inviting Others into Your Game of Outliving Cancer

Overcoming the disease of cancer is incredibly difficult – both medically and mentally –, but sharing that experience with those we love can make it more enjoyable and successful.

Prespective Pieces Cancer

Merlin L. Marquard

Mar 13, 2026 — 5 min read

Correction: Recent Retraction of a Case Study on Fenbendazole Use in Cancer Patients

A paper, which we've referenced in the past, has been retracted. We thus issue a correction as to keep you on the bleeding edge of scientific insight.

Cancer Corrections

Merlin L. Marquard

Feb 25, 2026 — 2 min read

On the Gamification of Cancer Survival

A cancer diagnosis is one of the most daunting and stressful events in a cancer patient's life. So, how can we frame this challenge to make it a bit less stressful and dire?

Prespective Pieces

Merlin L. Marquard

Feb 14, 2026 — 6 min read

In Defence of Classical Care and Classically Trained Physicians and Nurses

The limitations of classical care in no way are a condemnation of it. Much more their understanding can enable us to use classical care more effectively and with less frustration.

Prespective Pieces

Merlin L. Marquard

Feb 11, 2026 — 3 min read

Anecdotal Success in Using a Soft Pharmaceutical Regimen to Lower the IL-6 Status in a Patient with Malignant Pleural Mesothelioma

4 months of treatment with a pharmaceutical plan formulated to suppress IL-6 over-expression in one patient has shown first success. Continuation and reproducibility of the effect remain to be seen.

Cancer Internal Articles

Merlin L. Marquard

Feb 5, 2026 — 5 min read

Correction: Ganoderma Lucidum Suppresses IL-6 only Inconsistently with Variance between Experiments

In a prior article, information about discrepancies in the effect of Ganoderma lucidum on IL-6 profiles. This is a correction to that article.

Corrections

Merlin L. Marquard

Jan 23, 2026 — 2 min read

On The Therapeutic Potential of Tocilizumab in IL-6-Positive Cancers

IL-6 is an immune signaller misappropriated by many cancer types to engender immune senescence and proliferative auto-signalling. Disrupting this misappropriation can help overcome IL-6-positive cancers.

Cancer Immune System

Merlin L. Marquard

Jan 17, 2026 — 4 min read